Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A disease involving the connective tissue.
Biomarker and diagnostic research for connective tissue disorder has been reported in the published literature.
29 clinical trials registered, 18 recruiting. Pipeline includes 3 PHASE4, 2 PHASE3, 2 PHASE2.
NCT ID | Title | Phase | Sponsor | Status |
|---|---|---|---|---|
[NCT04398628](https://clinicaltrials.gov/study/NCT04398628) | ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 1:58 AM UTC
— |
American Thrombosis and Hemostasis Network |
RECRUITING |
[NCT07319598](https://clinicaltrials.gov/study/NCT07319598) | A Study to Test Tetrandrine Tablets for Connective Tissue Disease-Related Lung Disease | PHASE4 | Peking University Third Hospital | RECRUITING |
[NCT06716606](https://clinicaltrials.gov/study/NCT06716606) | A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE) | PHASE3 | GlaxoSmithKline | RECRUITING |
[NCT04095351](https://clinicaltrials.gov/study/NCT04095351) | Connective Tissue Diseases and Lung Manifestations | — | Medical University Innsbruck | RECRUITING |
[NCT02234388](https://clinicaltrials.gov/study/NCT02234388) | Undifferentiated Connective Tissue Disease Registry | — | Hospital for Special Surgery, New York | RECRUITING |
392 publications have been identified in PubMed for connective tissue disorder. Kisho has analyzed 129 by research type. Research spans Review / Meta-Analysis (28%), Basic Science / Preclinical (27%), and Epidemiology / Natural History (20%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 36 | 28% |
Laboratory research | 35 | 27% |
Disease patterns and progression | 26 | 20% |
Patient case studies | 22 | 17% |
Testing and diagnosis research | 5 | 4% |
Other research | 2 | 2% |
New treatment approaches | 2 | 2% |
Clinical study results | 1 | 1% |
Adigun R (2026). [PMID: 28613625](https://pubmed.ncbi.nlm.nih.gov/28613625/). *Unknown Journal*. [Review / Meta-Analysis]
Alcocer AD (2026). [PMID: 41915433](https://pubmed.ncbi.nlm.nih.gov/41915433/). *Physiology (Bethesda)*. [Review / Meta-Analysis]
Meyers AL (2026). [PMID: 32491606](https://pubmed.ncbi.nlm.nih.gov/32491606/). *Unknown Journal*. [Gene Therapy / Novel Therapeutics]
Alkurdi D (2026). [PMID: 41209845](https://pubmed.ncbi.nlm.nih.gov/41209845/). *JID Innov*. [Clinical Trial Publication]
Miolo G (2026). [PMID: 41338889](https://pubmed.ncbi.nlm.nih.gov/41338889/). *J Proteome Res*. [Basic Science / Preclinical]
Cohen SA (2026). [PMID: 41496654](https://pubmed.ncbi.nlm.nih.gov/41496654/). *Curr Opin Ophthalmol*. [Review / Meta-Analysis]
Sahu G (2026). [PMID: 42199566](https://pubmed.ncbi.nlm.nih.gov/42199566/). *Cureus*. [Epidemiology / Natural History]
Yang X (2026). [PMID: 41813411](https://pubmed.ncbi.nlm.nih.gov/41813411/). *Taiwan J Obstet Gynecol*. [Other]
Zheng A (2025). [PMID: 39800123](https://pubmed.ncbi.nlm.nih.gov/39800123/). *J Vasc Surg*. [Basic Science / Preclinical]
Choubey S (2025). [PMID: 40613922](https://pubmed.ncbi.nlm.nih.gov/40613922/). *Rheumatol Int*. [Review / Meta-Analysis]
AI-curated news mentioning connective tissue disorder
Updated Aug 7, 2026
A narrative review highlights the role of exhaled nitric oxide measurement in patients with connective tissue diseases linked to interstitial lung disease. This research could provide insights into non-invasive monitoring and management strategies for affected patients.
A new methodology has been developed for reaching consensus on high-level concepts in rare connective tissue and musculoskeletal diseases. This approach aims to enhance understanding and research in these complex disease areas.